Last edition
News about
NeoImmuneTech's NT-I7 Receives FDA ODD for Advanced Pancreatic Cancer Treatment
Pancreatic cancer is an aggressive tumor-type associated with extremely poor prognosis.
Alcami Strengthens Market Position with Acquisition of Pacific Pharmaceutical Services
In addition to the acquisition of PPS, Alcami is strategically expanding its central North Carolina pharma storage and service footprint with the opening of a new 65,000 square foot facility co-located near the Research Triangle Park's biotech and pharma hub.
Jubilant Pharma Plans Strategic Exit from Sofie Biosciences
The pharmaceutical giant's wholly-owned subsidiary had previously invested USD 25 million in Sofie Biosciences in November 2020, currently holding a noteworthy 25.8 percent stake in the company.
The trial's efficacy endpoints further underscore the superiority of Lutathera, with a progression-free survival hazard ratio of 0.28 and a median progression-free survival of 22.8 months, significantly outperforming high-dose octreotide LAR.
Daewoong Pharmaceutical's Bersiporocin Receives 'Orphan Drug Designation' in Europe
This first-in-class PRS inhibitor has recently received 'Orphan Drug Designation (ODD)' from the European Medicines Agency (EMA), adding to its earlier designation by the US FDA for both IPF and systemic sclerosis.
Esaote Unveils Two New Ultrasound Systems at Arab Health: MyLabA50 and MyLabA70
MyLab™A50 and MyLab™A70 embody the concept of Agility and are engineered to perform seamlessly in diverse clinical settings. With compact footprint, battery-operated lightweight and mobile design they meet the demands of most healthcare professionals.
Glenmark Specialty S.A. (GSSA), a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) announced the signing of a license agreement with JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD (Jiangsu Alphamab) and 3D MEDICINES INC. (3D Medicines), (together as the Licensors), for KN035 (Envafolimab) for India, Asia Pacific.
MolecuLight Wins VA Contract for Advanced Wound Imaging Devices
This contract, facilitated through the VA FSS program, reinforces MolecuLight's commitment to addressing healthcare requirements for Veterans and other federal government agencies.
Bormioli Pharma and Loop Industries Introduce 100 Percent Recycled PET Pharmaceutical Packaging
A recent laboratory test, conducted by a globally recognized leader in the field, affirmed that Loop™ PET resin meets the stringent standards outlined by the EU Pharmacopeia and US Pharmacopeia.
SHL Medical, SteriPack Group Forms Partnership for Drug Delivery System Assembly Services
The collaboration aims to establish a pre-validated final assembly service at the SteriPack facility in Poland, offering enhanced flexibility in supply chain strategies for their customers.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy